Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8<sup>+</sup>T cells eradicates peritoneal metastases in mouse models-Reference-Cited by-同舟云学术

Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8⁺T cells eradicates peritoneal metastases in mouse models

Published:2022-12-15 Issue:1 Volume:12 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Di Trani Claudia Augusta¹²,Cirella Assunta¹²,Arrizabalaga Leire¹²,Bella Ángela¹²,Fernandez-Sendin Myriam¹²,Russo-Cabrera Joan Salvador¹²,Gomar Celia¹²,Olivera Irene¹²,Bolaños Elizabeth¹²,González-Gomariz José¹²,Álvarez Maite¹²³,Etxeberria Iñaki¹²,Palencia Belen¹²,Teijeira Álvaro¹²³,Melero Ignacio¹²³⁴⁵,Berraondo Pedro¹²³,Aranda Fernando¹²^ORCID

Affiliation:

1. Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain

2. Navarra Institute for Health Research (IDISNA), Pamplona, Spain

3. Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain

4. Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain

5. Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2022.2147317

Reference80 articles.

1. Peritoneal carcinomatosis

2. Peritoneal carcinomatosis of gastrointestinal tumors: Where are we now?

3. Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review

4. Primary and metastatic peritoneal surface malignancies

5. Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regional and intratumoral adoptive T-cell therapy;Immuno-Oncology and Technology;2024-12

2. Non-viral delivery of RNA for therapeutic T cell engineering;Advanced Drug Delivery Reviews;2024-05

3. Exploiting innate immunity for cancer immunotherapy;Molecular Cancer;2023-11-27

4. The significance of the omentum in locoregional immunotherapy for peritoneal carcinomatosis;OncoImmunology;2023-11-20

5. From structural design to delivery: mRNA therapeutics for cancer immunotherapy;Exploration;2023-11-17